Previous Episode: Biomolecules: Interferon beta

This episodes highlight a recent publication of the phase 3 clinical trial of dapagliflozine forĀ  COVID-19 patients with cardiometabolic risk factors.

Support the show (https://www.patreon.com/bioxpressions)